Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: A systematic review and meta-analysis of outcomes.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
04 2021
Historique:
revised: 29 01 2021
received: 13 05 2020
accepted: 29 01 2021
pubmed: 4 3 2021
medline: 22 9 2021
entrez: 3 3 2021
Statut: ppublish

Résumé

Magnetic resonance-guided laser interstitial laser therapy (MRgLITT) and radiofrequency ablation (RFA) represent two minimally invasive methods for the treatment of drug-refractory mesial temporal lobe epilepsy (mTLE). We performed a systematic review and a meta-analysis to compare outcomes and complications between MRgLITT, RFA, and conventional surgical approaches to the temporal lobe (i.e., anterior temporal lobe resection [ATL] or selective amygdalohippocampectomy [sAHE]). Forty-three studies (13 MRgLITT, 6 RFA, and 24 surgery studies) involved 554, 123, 1504, and 1326 patients treated by MRgLITT, RFA, ATL, or sAHE, respectively. Engel Class I (Engel-I) outcomes were achieved after MRgLITT in 57% (315/554, range = 33.3%-67.4%), RFA in 44% (54/123, range = 0%-67.2%), ATL in 69% (1032/1504, range = 40%-92.9%), and sAHE in 66% (887/1326, range = 21.4%-93.3%). Meta-analysis revealed no significant difference in seizure outcome between MRgLITT and RFA (Q = 2.74, p = .098), whereas ATL and sAHE were both superior to MRgLITT (ATL: Q = 8.92, p = .002; sAHE: Q = 4.33, p = .037) and RFA (ATL: Q = 6.42, p = .0113; sAHE: Q = 5.04, p = .0247), with better outcome in patients at follow-up of 60 months or more. Mesial hippocampal sclerosis (mTLE + hippocampal sclerosis) was associated with significantly better outcome after MRgLITT (Engel-I outcome in 64%; Q = 8.55, p = .0035). The rate of major complications was 3.8% for MRgLITT, 3.7% for RFA, 10.9% for ATL, and 7.4% for sAHE; the differences did not show statistical significance. Neuropsychological deficits occurred after all procedures, with left-sided surgeries having a higher rate of verbal memory impairment. Lateral functions such as naming or object recognition may be more preserved in MRgLITT. Thermal therapies are effective techniques but show a significantly lower rate of Engel-I outcome in comparison to ATL and sAHE. Between MRgLITT and RFA there were no significant differences in Engel-I outcome, whereby the success of treatment seems to depend on the approach used (e.g., occipital approach). MRgLITT shows a similar rate of complications compared to RFA, whereas patients undergoing MRgLITT may experience fewer major complications compared to ATL or sAHE and might have a more beneficial neuropsychological outcome.

Identifiants

pubmed: 33656182
doi: 10.1111/epi.16846
doi:

Types de publication

Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

831-845

Informations de copyright

© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Strzelczyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. Pharmacoeconomics. 2008;26(6):463-76.
Fiest Kirsten M., Sauro Khara M., Wiebe Samuel, Patten Scott B., Kwon Churl-Su, Dykeman Jonathan, Pringsheim Tamara, Lorenzetti Diane L., Jetté Nathalie. Prevalence and incidence of epilepsy. Neurology. 2017;88: 3:296-303. doi: 10.1212/wnl.0000000000003509
Asadi-Pooya AA, Stewart GR, Abrams DJ, Sharan A. Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017;99:662-6.
Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-8.
Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015;313(3):285-93.
Brotis AG, Giannis T, Kapsalaki E, Dardiotis E, Fountas KN. Complications after anterior temporal lobectomy for medically intractable epilepsy: a systematic review and meta-analysis. Stereotact Funct Neurosurg. 2019;97(2):69-82.
Prince E, Hakimian S, Ko AL, Ojemann JG, Kim MS, Miller JW. Laser interstitial thermal therapy for epilepsy. Curr Neurol Neurosci Rep. 2017;17(9):1-13.
Gross RE, Mahmoudi B, Riley JP. Less is more: novel less-invasive surgical techniques for mesial temporal lobe epilepsy that minimize cognitive impairment. Curr Opin Neurol. 2015;28(2):182-91.
Ahmed M, Brace CL, Lee FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351-69.
Salem U, Kumar VA, Madewell JE, Schomer DF, de Almeida Bastos DC, Zinn PO, et al. Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT). Cancer Imaging. 2019;19(1):65.
Gross RE, Willie JT, Drane DL. The role of stereotactic laser amygdalohippocampotomy in mesial temporal lobe epilepsy. Neurosurg Clin N Am. 2016;27(1):37-50.
Drane DL. MRI-guided stereotactic laser ablation for epilepsy surgery: promising preliminary results for cognitive outcome. Epilepsy Res. 2018;142:170-5.
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777.
West S, Nevitt SJ, Cotton J, Gandhi S, Weston J, Sudan A, et al. Surgery for epilepsy. Cochrane Database Syst Rev. 2019;6(6):CD010541.
Jain P, Tomlinson G, Snead C, Sander B, Widjaja E. Systematic review and network meta-analysis of resective surgery for mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2018;89(11):1138-44.
Xu KE, Wang X, Guan Y, Zhao M, Zhou J, Zhai F, et al. Comparisons of the seizure-free outcome and visual field deficits between anterior temporal lobectomy and selective amygdalohippocampectomy: a systematic review and meta-analysis. Seizure. 2020;81:228-35.
Engel J, Jr.. Outcome with respect to epileptic seizures. In: J. Engel, Jr. (ed.), Surgical treatment of the epilepsies. 2nd, pp. 609-21. Raven Press, New York, NY 1993.
Ahmed M. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. J Vasc Interv Radiol. 2014;25(11):1706-8.
Zeng X, Zhang Y, Kwong JSW, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2-10.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
Wu C, Jermakowicz WJ, Chakravorti S, Cajigas I, Sharan AD, Jagid JR, et al. Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: a multicenter study of 234 patients. Epilepsia. 2019;60(6):1171-83.
Kang JY, Wu C, Tracy J, Lorenzo M, Evans J, Nei M, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2):325-34.
Waseem H, Vivas AC, Vale FL. MRI-guided laser interstitial thermal therapy for treatment of medically refractory non-lesional mesial temporal lobe epilepsy: outcomes, complications, and current limitations: a review. J Clin Neurosci. 2017;38:1-7.
Jermakowicz WJ, Kanner AM, Sur S, Bermudez C, D'Haese P-F, Kolcun JPG, et al. Laser thermal ablation for mesiotemporal epilepsy: analysis of ablation volumes and trajectories. Epilepsia. 2017;58(5):801-10.
Youngerman BE, Oh JY, Anbarasan D, Billakota S, Casadei CH, Corrigan EK, et al. Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography. Epilepsia. 2018;59(3):595-606.
Grewal SS, Zimmerman RS, Worrell G, Brinkmann BH, Tatum WO, Crepeau AZ, et al. Laser ablation for mesial temporal epilepsy: a multi-site, single institutional series. J Neurosurg. 2019. 130: 2055-2062. doi: 10.3171/2018.2.JNS171873
Greenway MRF, Lucas JA, Feyissa AM, Grewal S, Wharen RE, Tatum WO. Neuropsychological outcomes following stereotactic laser amygdalohippocampectomy. Epilepsy Behav. 2017;75:50-5.
Tao JX, Wu S, Lacy M, Rose S, Issa NP, Yang CW, et al. Stereotactic EEG-guided laser interstitial thermal therapy for mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2018;89(5):542-8.
Petito GT, Wharen RE, Feyissa AM, Grewal SS, Lucas JA, Tatum WO. The impact of stereotactic laser ablation at a typical epilepsy center. Epilepsy Behav. 2018;78:37-44.
Vakharia VN, Sparks R, Li K, O'Keeffe AG, Miserocchi A, McEvoy AW, et al. Automated trajectory planning for laser interstitial thermal therapy in mesial temporal lobe epilepsy. Epilepsia. 2018;59(4):814-24.
Le S, Ho AL, Fisher RS, Miller KJ, Henderson JM, Grant GA, et al. Laser interstitial thermal therapy (LITT): seizure outcomes for refractory mesial temporal lobe epilepsy. Epilepsy Behav. 2018;89:37-41.
Zhao Q, Shi T, Cui S, Wu Z, Wang W, Jia Y, et al. Stereotactic bilateral transfrontal minimal radiofrequency thermocoagulation of the amygdalohippocampal complex for bilateral medial temporal lobe epilepsy: a retrospective study of 12 patients. Epileptic Disord. 2017;19(2):152-65.
Vojtěch Z, Malíková H, Krámská L, Anýž J, Syrůček M, Zámečník J, et al. Long-term seizure outcome after stereotactic amygdalohippocampectomy. Acta Neurochir. 2014;156(8):1529-37.
Moles A, Guénot M, Rheims S, Berthiller J, Catenoix H, Montavont A, et al. SEEG-guided radiofrequency coagulation (SEEG-guided RF-TC) versus anterior temporal lobectomy (ATL) in temporal lobe epilepsy. J Neurol. 2018;265(9):1998-2004.
Cossu M, Fuschillo D, Casaceli G, Pelliccia V, Castana L, Mai R, et al. Stereoelectroencephalography-guided radiofrequency thermocoagulation in the epileptogenic zone: a retrospective study on 89 cases. J Neurosurg. 2015;123(6):1358-67.
Wu Z, Zhao Q, Tian Z, Zhang J, Xiao X, Lin H, et al. Efficacy and safety of a new robot-assisted stereotactic system for radiofrequency thermocoagulation in patients with temporal lobe epilepsy. Exp Ther Med. 2014;7(6):1728-32.
Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922-30.
Alonso-Vanegas MA, Freire Carlier ID, San-Juan D, Martínez AR, Trenado C. Parahippocampectomy as a new surgical approach to mesial temporal lobe epilepsy caused by hippocampal sclerosis: a pilot randomized comparative clinical trial. World Neurosurg. 2018;110:e1063-71.
Schramm J, Lehmann TN, Zentner J, Mueller CA, Scorzin J, Fimmers R, et al. Randomized controlled trial of 2.5-cm versus 3.5-cm mesial temporal resection-part 2: volumetric resection extent and subgroup analyses. Acta Neurochir. 2011;153:221-8.
Clusmann H, Schramm J, Kral T, Helmstaedter C, Ostertun B, Fimmers R, et al. Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg. 2002;97(5):1131-41.
Mittal S, Montes JL, Farmer J-P, Rosenblatt B, Dubeau F, Andermann F, et al. Long-term outcome after surgical treatment of temporal lobe epilepsy in children. J Neurosurg. 2005;103(5):401-12.
Schmeiser B, Wagner K, Schulze-Bonhage A, Mader I, Wendling A-S, Steinhoff BJ, et al. Surgical treatment of mesiotemporal lobe epilepsy: which approach is favorable? Neurosurgery. 2017;81(6):992-1003.
Wendling A-S, Hirsch E, Wisniewski I, Davanture C, Ofer I, Zentner J, et al. Selective amygdalohippocampectomy versus standard temporal lobectomy in patients with mesial temporal lobe epilepsy and unilateral hippocampal sclerosis. Epilepsy Res. 2013;104(1-2):94-104.
Nascimento FA, Gatto LAM, Silvado C, Mäder-Joaquim MJ, Moro MS, Araujo JC, et al. Anterior temporal lobectomy versus selective amygdalohippocampectomy in patients with mesial temporal lobe epilepsy. Arq Neuropsiquiatr. 2016;74(1):35-43.
Paglioli E, Palmini A, Portuguez M, Paglioli E, Azambuja N, Costa JCD, et al. Seizure and memory outcome following temporal lobe surgery: selective compared with nonselective approaches for hippocampal sclerosis. J Neurosurg. 2006;104(1):70-8.
Mathon B, Bielle F, Samson S, Plaisant O, Dupont S, Bertrand A, et al. Predictive factors of long-term outcomes of surgery for mesial temporal lobe epilepsy associated with hippocampal sclerosis. Epilepsia. 2017;58(8):1473-85.
Morino M, Uda T, Naito K, Yoshimura M, Ishibashi K, Goto T, et al. Comparison of neuropsychological outcomes after selective amygdalohippocampectomy versus anterior temporal lobectomy. Epilepsy Behav. 2006;9(1):95-100.
Renowden SA, Matkovic Z, Adams CBT, Carpenter K, Oxbury S, Molyneux AJ, et al. Selective amygdalohippocampectomy for hippocampal sclerosis: postoperative MR appearance. AJNR Am J Neuroradiol. 1995;16(9):1855-61.
Lee T, Mackenzie RA, Walker AJ, Matheson JM, Sachdev P. Effects of left temporal lobectomy and amygdalohippocampectomy on memory. J Clin Neurosci. 1997;4(3):314-9.
Sagher O, Thawani JP, Etame AB, Gomez-Hassan DM. Seizure outcomes and mesial resection volumes following selective amygdalohippocampectomy and temporal lobectomy. Neurosurg Focus. 2012;32(3):1-8.
Tanriverdi T, Dudley RWR, Hasan A, Jishi AA, Hinai QA, Poulin N, et al. Memory outcome after temporal lobe epilepsy surgery: corticoamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg. 2010;113(6):1164-75.
Elliott CA, Broad A, Narvacan K, Steve TA, Snyder T, Urlacher J, et al. Seizure outcome in pediatric medically refractory temporal lobe epilepsy surgery: selective amygdalohippocampectomy versus anterior temporal lobectomy. J Neurosurg Pediatr. 2018;22:276-82.
Bate H, Eldridge P, Varma T, Wieshmann UC. The seizure outcome after amygdalohippocampectomy and temporal lobectomy. Eur J Neurol. 2007;14(1):90-4.
Arruda F, Cendes F, Andermann F, Dubeau F, Villemure JG, Jones-Gotman M, et al. Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal. Ann Neurol. 1996;40(3):446-50.
Bujarski KA, Hirashima F, Roberts DW, Jobst BC, Gilbert KL, Roth RM, et al. Long-term seizure, cognitive, and psychiatric outcome following trans-middle temporal gyrus amygdalohippocampectomy and standard temporal lobectomy. J Neurosurg. 2013;119(1):16-23.
Kellet MW, Smith DF, Baker GA, Chadwick DW. Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry. 1997;63:52-8.
Mackenzie RA, Matheson J, Ellis M, Klamus J. Selective versus non-selective temporal lobe surgery for epilepsy. J Clin Neurosci. 1997;4(2):152-4.
Schijns OEMG, Bien CG, Majores M, von Lehe M, Urbach H, Becker A, et al. Presence of temporal gray-white matter abnormalities does not influence epilepsy surgery outcome in temporal lobe epilepsy with hippocampal sclerosis. Neurosurgery. 2011;68(1):98-106.
Tanriverdi T, Olivier A, Poulin N, Andermann F, Dubeau F. Long-term seizure outcome after mesial temporal lobe epilepsy surgery: corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg. 2008;108(3):517-24.
Vojtěch Z, Krámská L, Malíková H, Seltenreichová K, Procházka T, Kalina M, et al. Cognitive outcome after stereotactic amygdalohippocampectomy. Seizure. 2012;21(5):327-33.
Lee CY, Li HT, Wu T, Cheng MY, Lim SN, Lee ST. Efficacy of limited hippocampal radiofrequency thermocoagulation for mesial temporal lobe epilepsy. J Neurosurg. 2019;131(3):781-9.
Mcintosh AM, Kalnins RM, Mitchell LA, Fabinyi GCA, Briellmann RS, Berkovic SF. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain. 2004;127:2018-30.
Marks WJ. Long-term outcomes of temporal lobe epilepsy surgery. Epilepsy Curr. 2003;3(5):178-80.
Téllez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain. 2005;128:1188-98.
Drane DL, Loring DW, Voets NL, Price M, Ojemann JG, Willie JT, et al. Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia. 2015;56(1):101-13.
Waseem H, Osborn KE, Schoenberg MR, Kelley V, Bozorg A, Cabello D, et al. Laser ablation therapy: an alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50. Epilepsy Behav. 2015;51:152-7.
Donos C, Breier J, Friedman E, Rollo P, Johnson J, Moss L, et al. Laser ablation for mesial temporal lobe epilepsy: surgical and cognitive outcomes with and without mesial temporal sclerosis. Epilepsia. 2018;59(7):1421-32.
Egan RA, Shults WT, So N, Burchiel K, Kellogg JX, Salinsky M. Visual field deficits in conventional anterior temporal lobectomy versus amygdalohippocampectomy. Neurology. 2000;55(12):1818-22.
Donos C, Rollo P, Tombridge K, Johnson JA, Tandon N. Visual field deficits following laser ablation of the hippocampus. Neurology. 2020;94(12):1303-13.
Gross RE, Stern MA, Willie JT, Fasano RE, Saindane AM, Soares BP, et al. Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Ann Neurol. 2018;83(3):575-87.
Georgiadis I, Kapsalaki EZ, Fountas KN. Temporal lobe resective surgery for medically intractable epilepsy: a review of complications and side effects. Epilepsy Res Treat. 2013;2013:752195.
Toczek MT, Morrell MJ, Silverberg GA, Lowe GM. Cerebellar hemorrhage complicating temporal lobectomy: report of four cases. J Neurosurg. 1996;85(4):718-22.
De Paola L, Troiano AR, Germiniani FMB, Coral P, Della Coletta MV, Silvado CES, et al. Cerebellar hemorrhage as a complication of temporal lobectomy for refractory medial temporal epilepsy: report of three cases. Arq Neuropsiquiatr. 2004;62(2B):519-22.
Lackner P, Koppelstaetter F, Ploner P, Sojer M, Dobesberger J, Walser G, et al. Cerebral vasospasm following temporal lobe epilepsy surgery. Neurology. 2012;78(16):1215-20.
Helmstaedter C, Richter S, Röske S, Oltmanns F, Schramm J, Lehmann T-N. Differential effects of temporal pole resection with amygdalohippocampectomy versus selective amygdalohippocampectomy on material-specific memory in patients with mesial temporal lobe epilepsy. Epilepsia. 2008;49(1):88-97.
Von Rhein B, Nelles M, Urbach H, Von Lehe M, Schramm J, Helmstaedter C. Neuropsychological outcome after selective amygdalohippocampectomy: subtemporal versus transsylvian approach. J Neurol Neurosurg Psychiatry. 2012;83(9):887-93.

Auteurs

Konstantin Kohlhase (K)

Department of Neurology, Epilepsy Center Frankfurt Rhine-Main, University Hospital Frankfurt, Frankfurt am Main, Germany.
Landes-Offensive zur Entwicklung wissenschaftlich-ökonomischer Exzellen, Center for Personalized and Translational Epilepsy Research, Goethe University Frankfurt, Frankfurt am Main, Germany.

Johann Philipp Zöllner (JP)

Department of Neurology, Epilepsy Center Frankfurt Rhine-Main, University Hospital Frankfurt, Frankfurt am Main, Germany.
Landes-Offensive zur Entwicklung wissenschaftlich-ökonomischer Exzellen, Center for Personalized and Translational Epilepsy Research, Goethe University Frankfurt, Frankfurt am Main, Germany.

Nitin Tandon (N)

Department of Neurosurgery, McGovern Medical School at University of Texas Health Science Center at Houston, Houston, Texas, USA.

Adam Strzelczyk (A)

Department of Neurology, Epilepsy Center Frankfurt Rhine-Main, University Hospital Frankfurt, Frankfurt am Main, Germany.
Landes-Offensive zur Entwicklung wissenschaftlich-ökonomischer Exzellen, Center for Personalized and Translational Epilepsy Research, Goethe University Frankfurt, Frankfurt am Main, Germany.

Felix Rosenow (F)

Department of Neurology, Epilepsy Center Frankfurt Rhine-Main, University Hospital Frankfurt, Frankfurt am Main, Germany.
Landes-Offensive zur Entwicklung wissenschaftlich-ökonomischer Exzellen, Center for Personalized and Translational Epilepsy Research, Goethe University Frankfurt, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH